Myocarditis Foundation Research Grants support early-career investigators studying inflammatory heart diseases to advance understanding, diagnosis, prevention, and treatment.
Funder: Myocarditis Foundation
Due Dates: December 1, 2026 (Annual application deadline)
Funding Amounts: Up to $40,000 total over 1–2 years under the 2026 award requirements
Summary: Seed funding supports early-career investigators studying myocarditis, pericarditis, and inflammatory cardiomyopathy to advance understanding, diagnosis, and treatment.
Key Information: The 2026 documents differ from the program webpage on funding, eligibility, and submission requirements; confirm discrepancies with Helene Webster.
The Myocarditis Foundation supports early-career researchers developing innovative basic, translational, and clinical studies of myocarditis and related inflammatory heart diseases. Its 2026 Early Career Research Award covers myocarditis, pericarditis, and inflammatory cardiomyopathy, including disease mechanisms, diagnostics, biomarkers, immunology, clinical management, epidemiology, prevention, and therapeutic development.
The program provides early funding to test ideas and generate preliminary data for larger funding applications, including NIH K- or R-series awards. It aims to build sustained research expertise while improving diagnosis, risk stratification, prevention, treatment, and patient outcomes. Mentorship and the applicant’s potential for research independence are central to the award.